Strengthening cancer research capacity in Oklahoma
Official title: Admin Core
Funded at University of Oklahoma Hlth Sciences Ctr · NIH-10936136 · Data updated 2026-11-12
This study is all about improving cancer research in Oklahoma to help develop better treatments, and it's for anyone interested in how new discoveries could benefit cancer patients like you.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Oklahoma Hlth Sciences Ctr NIH-funded |
| Lab location | 1 site (Oklahoma City, United States) |
| Project start | August 10, 2024 |
| Project end | June 30, 2029 |
| Funding year | 2024 |
| Award (this year) | $524,810 |
| NIH project number | 1P30GM154635-01 |
| Project ID | NIH-10936136 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research are individuals diagnosed with advanced cancer or those involved in cancer research initiatives.
✕Less likely to help
Patients with non-cancerous conditions or those not residing in Oklahoma may not receive direct benefits from this research.
What this research studies
This research focuses on enhancing the infrastructure and capacity for cancer research in Oklahoma through the renewal of the Center of Biomedical Research Excellence (COBRE) program. It aims to provide administrative and fiscal support to various research initiatives and pilot projects that foster innovative approaches to cancer treatment. The program will be led by Dr. Danny Dhanasekaran and will involve collaboration with other researchers and coordinators to ensure effective management and adherence to funding policies. Patients may benefit from the advancements in cancer therapies and research that emerge from this initiative.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer treatment options and better patient outcomes.
How similar studies have gone: Previous phases of the COBRE program have shown success in enhancing cancer research capabilities, indicating a promising continuation of this approach.
Where this research is happening
-
University of Oklahoma Hlth Sciences Ctr
Oklahoma City, United States Active
Researchers
- Principal investigator: Dhanasekaran, Danny N. — University of Oklahoma Hlth Sciences Ctr
- Study coordinator: Dhanasekaran, Danny N.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.